Latest Asx News

Felix Gold has transitioned from exploration to development with a metallurgical breakthrough producing military-grade antimony and is advancing pilot plant operations and government funding applications to meet US military demand.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

Magnum Mining & Exploration has accelerated its rare earth elements (REE) exploration with new drilling programs in Brazil and the acquisition of the Wet Mountains REE Project in Colorado, backed by a $7 million capital raise.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Fleetwood Limited has appointed Andrea Pidcock as its new CEO, bringing a wealth of operational and commercial leadership experience to the industrial and construction services company. Her appointment signals a strategic push towards operational excellence and growth through modern construction methods.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Fluence Corporation Limited has reported a robust FY 2025 with a 52.3% revenue increase and record new orders, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

TrivarX Limited has expanded its diagnostic portfolio by acquiring the Stabl-Im brain cancer imaging technology and reported strong clinical trial results validating its single-lead ECG algorithm for depression screening in US veterans.

Fluence Corporation reported robust revenue and EBITDA growth in FY 2025, driven by strong contributions from its Ivory Coast project and expanding Smart Product Solutions. Leadership changes aim to accelerate growth as the company eyes continued momentum in 2026.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Critical Resources Limited has significantly expanded its Mavis Lake Lithium Project in Ontario and progressed gold exploration in New Zealand, while securing exclusive rights to evaluate cutting-edge solid-state battery technology.